These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36967539)

  • 21. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
    Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
    Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colposcopy prediction of progression in human papillomavirus infections with minor cervical lesions.
    Del Pino M; Torne A; Alonso I; Mula R; Masoller N; Fuste V; Ordi J
    Obstet Gynecol; 2010 Dec; 116(6):1324-1331. PubMed ID: 21099598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer.
    Pillai MR; Chacko P; Kesari LA; Jayaprakash PG; Jayaram HN; Antony AC
    J Clin Pathol; 2003 Aug; 56(8):569-74. PubMed ID: 12890803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
    Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
    Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.
    Sharma S; Hussain S; Soni K; Singhal P; Tripathi R; Ramachandran VG; Sharma S; Das S; Pillai B; Bharadwaj M
    Tumour Biol; 2016 Apr; 37(4):4585-95. PubMed ID: 26508022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of cervical lesions in high-risk HPV (hr-HPV) positive women with ASC-US: a retrospective single-center study in China.
    Wang Z; Gu Y; Wang H; Chen J; Zheng Y; Cui B; Yang X
    Virol J; 2020 Nov; 17(1):185. PubMed ID: 33228715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix.
    De Brot L; Pellegrini B; Moretti ST; Carraro DM; Soares FA; Rocha RM; Baiocchi G; da Cunha IW; de Andrade VP
    Cancer Cytopathol; 2017 Feb; 125(2):138-143. PubMed ID: 27870295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.
    Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Arbyn M; Pawlita M;
    J Clin Microbiol; 2013 May; 51(5):1458-64. PubMed ID: 23447632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China.
    Wang X; Wu S; Li Y
    J Med Virol; 2021 Nov; 93(11):6355-6361. PubMed ID: 34232523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
    J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of human papilloma virus genotyping for the identification of neoplasm lesions in the cervix of women with abnormal cytology smears.
    Ciszek B; Heimrath J; Ciszek M
    Adv Clin Exp Med; 2012; 21(6):759-66. PubMed ID: 23457134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol.
    Torres-Poveda K; Bahena-Román M; Delgado-Romero K; Madrid-Marina V
    BMC Infect Dis; 2018 Nov; 18(1):582. PubMed ID: 30453958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
    Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
    Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis.
    Leung TW; Liu SS; Leung RC; Chu MM; Cheung AN; Ngan HY
    J Med Virol; 2015 Jun; 87(6):1022-33. PubMed ID: 25648229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between HPV-negative cervical lesions and cervical microenvironment.
    Zheng JJ; Miao JR; Wu Q; Yu CX; Mu L; Song JH
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):855-861. PubMed ID: 33218401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 40. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
    Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
    Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.